首页> 美国卫生研究院文献>Korean Journal of Ophthalmology : KJO >Pegylated Interferon-Associated Severe Retinopathy in a Patient with Chronic Hepatitis
【2h】

Pegylated Interferon-Associated Severe Retinopathy in a Patient with Chronic Hepatitis

机译:聚乙二醇化干扰素相关性严重视网膜病变在慢性肝炎患者中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This paper reports a case of pegylated interferon-associated retinopathy in a patient with chronic hepatitis C. A 32-year-old female with chronic hepatitis C undergoing pegylated interferon and ribavirin combination therapy complained of visual blurring. Features of interferon-associated retinopathy, including ocular complications such as cotton wool spots, retinal hemorrhages, macular edema, and branch retinal vein occlusion, were found in the fundus of both of her eyes. Pegylated interferon combination therapy was stopped, and the retinopathy of the patient was treated with intravitreal bevacizumab injections and panretinal photocoagulations. This case shows that pharmacokinetically improved pegylated interferon has ocular complications for patients with chronic hepatitis C. Accordingly, patients undergoing pegylated interferon treatment for hepatitis C need regular eye examinations for protection of their vision.
机译:本文报道了一例慢性丙型肝炎患者的聚乙二醇化干扰素相关性视网膜病变。一名32岁的慢性丙型肝炎女性接受聚乙二醇化干扰素和利巴韦林的联合治疗,其视力模糊。在她的两只眼睛的眼底都发现了与干扰素有关的视网膜病变的特征,包括眼部并发症,例如棉斑点,视网膜出血,黄斑水肿和视网膜分支静脉阻塞。停止聚乙二醇化干扰素联合治疗,并通过玻璃体内贝伐单抗注射和全视网膜光凝治疗患者的视网膜病变。该病例表明,药代动力学改善的聚乙二醇化干扰素对慢性丙型肝炎患者有眼部并发症。因此,接受聚乙二醇化干扰素治疗丙型肝炎的患者需要定期进行眼部检查以保护其视力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号